FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with treating oncological diseases with DNA-containing preparations. Moreover, one should apply a homologous DNA of biologically active size that comprises the complete genome of a physiologically and genetically healthy donor. Such a DNA should be introduced at a dosage that provides DNA concentration in blood plasma being either equal to or above maximally permissible concentration of 30 mcg/ml. The innovation in question provides natural homologous DNA repair at substituting mutation-carrying chromosomal parts that leads to cell cancerogenesis without any unfavorable effects at applying DNA at the above-mentioned dosage.
EFFECT: higher efficiency of therapy.
3 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
METHOD OF DETECTING STEM CANCER CELLS | 2013 |
|
RU2530170C1 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
PERSONALIZED METHOD OF BONE MARROW RESTITUTION FOR CONTROLLING PROGRESSION AND RECURRENCES OF VARIOUS CIVILIZATION DISEASES, PREVENTING AGING AND SUDDEN DEATH | 2023 |
|
RU2817892C1 |
BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
Authors
Dates
2007-12-27—Published
2006-01-16—Filed